| Excerpt | Reference |
|---|
| "Typhoid is still endemic in much of the developing world, and as travel increases, illnesses can and do skip around the world in a day." | ( Lifshitz, EI, 1996) |
| "Enteric fever is a serious public health problem in Pakistan, where multidrug-resistant salmonellosis causes enteric fever with increased morbidity and mortality." | ( Billoo, AG; Memon, HI; Memon, IA, 1997) |
| "Typhoid is a common and significant cause of morbidity between 1 and 5 years of age." | ( Bhan, MK; Clemens, JD; Kumar, R; Naficy, A; Rao, M; Reddaiah, VP; Sazawal, S; Singh, B; Sinha, A; Sood, S, 1999) |
| "Enteric fever is a systemic illness caused by Salmonella infection, with S." | ( Amatya, B; Kimula, Y; Kraus, MD, 1999) |
| "Enteric fever is a significant problem in the preschool years." | ( Kamoji, R; Parashar, Y; Singh, A; Verma, M, 2007) |
| "Enteric fever is an acute systemic febrile infection caused by Salmonella enterica serotype Typhi." | ( Chande, DS; Chaudhry, R; Duggal, N; Duggal, S; Hans, C; Mahajan, RK, 2007) |
| "Enteric fever is endemic in Mumbai and its diagnosis poses several problems." | ( Dastur, FD; Jog, S; Mehta, A; Rodrigues, C; Singhal, T; Soman, R, 2008) |
| "Enteric fever is a major public health problem in India." | ( Chander, J; Gupta, V; Kaur, J, 2009) |
| "Enteric fever is associated with a variety of clinical presentations and complications." | ( Dewan, P; Gomber, S; Kaushik, JS; Pooniya, V; Singhal, S, 2009) |
| "Enteric fever is a disease of developing countries associated with poor public health and low socio-economic indices." | ( Chugh, TD; Kothari, A; Pruthi, A, 2008) |
| "Enteric fever is a major public health problem in India." | ( Harish, BN; Menezes, GA; Parija, SC; Sarangapani, K, 2008) |
| "Enteric fever is an increasingly common diagnosis in returning travellers in the UK." | ( Clark, TW; Daneshvar, C; Pareek, M; Perera, N; Stephenson, I, 2010) |
| "Enteric fever is a global health problem and there is emerging drug resistance with some reports of re-emerging sensitivity to previously used antibiotics eg, chloramphenicol." | ( Abqari, S; Ahmad, F; Beig, FK, 2009) |
| "Typhoid is associated with a number of complications and is commonly seen in India." | ( George, P; Jhawar, M; Pawar, B, 2010) |
| "Typhoid is also a public health problem in Algeria." | ( Boudersa, F; Bouzenoune, F; Kellab Debbih, K; Kouhil, S; Nezzar, N, 2011) |
| "Typhoid fever (enteric fever) is a global health problem causing high morbidity and mortality, especially in endemic areas such as India." | ( Kumar, Y; Mani, KR; Sharma, A, 2011) |
| "Enteric fever is caused by Salmonella enterica serovars Typhi and Paratyphi A, B and C." | ( Butt, F; Sultan, F, 2011) |
| "Typhoid and paratyphoid are febrile illnesses, due to a bacterial infection, which remain common in many low- and middle-income countries." | ( Bhutta, ZA; Critchley, JA; Effa, EE; Garner, P; Lassi, ZS; Olliaro, PL; Sinclair, D, 2011) |
| "Vaccines against typhoid are commonly used by travelers but less so by residents of endemic areas." | ( Ali, M; Bhaduri, B; Bhattacharya, SK; Clemens, JD; Dougan, G; Dutta, S; Holt, KE; Manna, B; Ochiai, RL; Pickard, DJ, 2012) |
| "Outbreaks of enteric fever are a major health concern not only due to significant human morbidity and mortality but also fear of spread of multidrug resistant strains." | ( Bansal, N; Chander, J; Gupta, V; Singla, N, 2013) |
| "In India enteric fever is a major public health problem and Salmonella Typhi is the most common aetiologic agent." | ( Chaudhry, R; Dahiya, S; Das, BK; Kabra, SK; Kapil, A; Kumar, R; Lodha, RK; Sood, S, 2013) |
| "Enteric fever is a global public health problem, especially in developing countries." | ( Das Chugh, T; Jain, S, 2013) |
| "Enteric fever is a particular problem in travellers to endemic areas, especially those visiting friends and relatives." | ( Dave, J; Sefton, A, 2015) |
| "Typhoid is an important public health challenge for India, especially with the spread of antimicrobial resistance." | ( Grassly, NC; John, J; Van Aart, CJ, 2016) |
| "Enteric fever is a major cause of morbidity and mortality in tropical areas worldwide." | ( Divyashree, S; Nabarro, LE; Rupali, P; Veeraraghavan, B, 2016) |
| "Enteric fever is a multisystemic infection which largely affects children." | ( Ahmad Hatib, NA; Chong, CY; Krishnamoorthy, SS; Tan, NW; Tee, NW; Thoon, KC, 2016) |
| "Enteric fever is largely an imported disease in Singapore and has contributed to significant morbidity in children." | ( Ahmad Hatib, NA; Chong, CY; Krishnamoorthy, SS; Tan, NW; Tee, NW; Thoon, KC, 2016) |
| "Typhoid is endemic in many parts of southeast Asia." | ( Ahmed, M; Andleeb, S; Ansari, JK; Lodhi, M; Munir, T, 2016) |
| "Enteric fever is an important public-health problem in India." | ( Kumar, P; Kumar, R, 2017) |
| "Enteric fever is a systemic bacterial infection in humans that is endemic in Cambodia and for which antibiotic resistance is increasingly reported." | ( Bory, S; Chung, P; Gryseels, C; Jacobs, J; Kuijpers, LMF; Parry, A; Peeters Grietens, K; Sreng, B; Uk, S, 2018) |
| "The treatment of enteric fever is complicated by the emergence of antimicrobial resistant Salmonella Typhi." | ( Aljayyoussi, G; Angus, B; Ardrey, A; Biagini, GA; Feasey, NA; Gibani, MM; Jin, C; Liu, X; Moore, M; Parry, CM; Pennington, SH; Pollard, AJ, 2019) |
| "Drug-resistant enteric fever is widespread in low- and middle-income countries, and the situation is worsening." | ( Baker, S; Basnyat, B; Browne, AJ; Day, NPJ; Dolecek, C; Dunachie, S; Harriss, E; Hay, SI; Kashef Hamadani, BH; Kumaran, EAP; Longbottom, J; Lopez, AD; Moore, CE; Rao, P, 2020) |
| "Enteric fever is a common but serious disease that affects mostly children and adolescents in the developing countries." | ( Ganguly, NK; Gupta, SS; Mukhopadhyay, B; Sur, D, 2019) |
| "Paratyphoid is an attenuated disease of typhoid fever caused by Salmonella Paratyphi." | ( Heinitz, S; Lippmann, N; Lübbert, C; Trawinski, H; von Braun, A; Wendt, S, 2020) |
| "Since enteric fever is endemic in India, accurate drug susceptibility surveillance is crucial to ensure empiric management of enteric fever is appropriate." | ( Bari, AK; Kokare, RS; Patel, K; Pereira, JV; Poojary, A, 2021) |
| "Enteric fever is a systemic infection caused by Salmonella enterica serovar Typhi and Salmonella enterica serovar Paratyphi A, B, and C." | ( Ghouri, N; Mahesar, M; Noreen, S; Shahid, S, 2021) |
| "Enteric fever is a potentially life-threatening acute febrile systemic infection and is diagnosed by isolating a pathogen on culture." | ( Hussain, W; Qamar, FN; Qureshi, S, 2022) |
| "Typhoid is known to be heterogenous in time and space, with documented spatiotemporal clustering and hotspots associated with environmental factors." | ( Arya, A; Bavdekar, A; Dutta, S; Ganesan, SK; Gunasekaran, A; John, J; Kang, G; Kanungo, S; Karthikeyan, AS; Kumar Jaganathan, S; Mohan, VR; Natarajan Sindhu, K; Ramanujam, K; Rongsen-Chandola, T; Shrivastava, A; Sinha, B; Srinivasan, M, 2021) |
| "Enteric fever is a major contributor to disease and death among children." | ( Gupta, D; Saigal, K; Saikia, D, 2021) |
| "Enteric fever is predominantly managed as an outpatient condition in endemic settings but there is little evidence to support this approach in non-endemic settings." | ( Brown, M; Godbole, G; Heyderman, R; McCann, N; Morris-Jones, S; Nabarro, L; Patel, T, 2022) |
| "MDR and XDR enteric fever are a major concern." | ( Ahmad, M; Shah, N; Siddiqui, MA, 2023) |
| "Enteric fever is an acute systemic infectious disease associated with substantial morbidity and mortality in low- and middle-income countries (LMIC), with a global burden of 14." | ( Ashraf, J; Ghanchi, N; Greig, D; Hasan, R; Hasan, Z; Irfan, S; Kanji, A; Nair, S; Qamar, F; Razzak, SA, 2023) |
| "Enteric fever is one of the most common infectious diseases in the economically developing world and this bacterial infection is the common most cause of fever in travelers to these endemic areas." | ( Mehta, KK, 2023) |
| "Enteric fever is a major health problem in Bangladesh." | ( Alamgir, F; Sharmin, S, 2023) |
| "Typhoid fever, or enteric fever, is a highly fatal infectious disease that affects over 9 million people worldwide each year, resulting in more than 110,000 deaths." | ( Ahmed, T; Ahmmed, F; Aziz, AB; Chowdhury, F; Clemens, JD; Hoque, M; Im, J; Islam, MT; Jeon, HJ; Kang, SS; Khan, AI; Khanam, F; Kim, DR; Kim, JH; Liu, X; Marks, F; Pak, G; Park, J; Qadri, F; Tadesse, BT; Zaman, K, 2023) |
| Excerpt | Reference |
|---|
| "At our clinic 185 patients with severe typhoid fever were treated." | ( Ramirez, R; Rios, R, 1979) |
| "In the treatment of typhoid fever, co-trimoxazole seems to be a potent drug which can replace chloramphenicole." | ( Werner, GT, 1977) |
| "For the treatment of the chronic typhoid carrier ampicillin is most frequently used, but amoxycillin and co-trimoxazole seem to be just as effective." | ( Herzog, C, 1976) |
| "Thirty adults with proved typhoid fever were treated with amoxycillin 1 g six-hourly by mouth for an average of 14 days because of haematological contraindications to chloramphenicol." | ( Adnan, M; Afifi, AM; El Garf, AA, 1976) |
| "In the course of a typhoid epidemic during the autumn of 1974 in the Heidelberg region 74 persons were treated in hospital." | ( Bamberger, M; Gasparaitis, A; Kredel, L; Schettler, G, 1975) |
| "Additional studies--in volunteers with typhoid fever treated with chloramphenicol, in a volunteer with typhoid fever receiving cefazolin and gentamicin, and in untreated rhesus monkeys infected with Salmonella typhimurium--provided evidence that the increase in serum iron concentration during the febrile phase was the result of chloramphenicol therapy, whereas the increase in serum zinc concentrations was a disease-related phenomenon." | ( Beisel, WR; Bostian, KA; DuPont, HL; Hornick, RB; Kluge, RM; Pekarek, RS; Wannemacher, RW, 1975) |
| "Twenty-three patients with typhoid fever diagnosed by blood culture were treated with co-trimoxazole (trimethoprim/sulphamethoxazole, 1 :5) at a dosage of 10 mg trimethoprim/kg/day in two divided daily doses for 10 days." | ( Ali Omer, MI, 1975) |
| "Two patients with typhoid fever relapsed 6 weeks after finishing treatment." | ( Allen, DM; Chew, SK; Lim, YS; Monteiro, EH, 1992) |
| "Recently we experienced two male typhoid patients who required additional treatment with CP sodium succinate (CP succinate) to OFLX therapy." | ( Doi, H; Honda, S; Ichimura, H; Koda, T; Kurimura, O; Tamura, I, 1990) |
| "The effect on mouse typhoid infection of a 3-day treatment of female virgin mice with 1 mg/day of female sex hormones (estrogen or progesterone), maintaining the same hormonal levels observed in pregnant mice for 30 days, was investigated in order to clarify the mechanisms of altered resistance during pregnancy." | ( Emoto, M; Hamuro, A; Kashiba, S; Katsui, N; Kita, E; Nishikawa, F; Oku, D; Yagyu, Y, 1989) |
| "Seventy-one patients suffering from typhoid or paratyphoid fever were treated with trimethoprim." | ( Gargalianos, P; Geddes, AM; Herzog, C; Jackson, PT, 1986) |
| "Ofloxacin was also effective in the treatment of enteric fever, in which eradication was achieved in all seven patients." | ( Sahaphong, S; Srimuang, S; Tanphaichitra, D, 1986) |
| "The response of 310 patients with typhoid or paratyphoid fevers to current antibiotic therapy was studied retrospectively." | ( Fallon, RJ; Mandal, BK; Mayon-White, RT; Scott, AC, 1988) |
| "Ninety-four patients with Salmonella typhi infection hospitalized and treatment." | ( Colak, H; Usluer, G, 1987) |
| "In 45 patients in whom typhoid fever was confirmed by culture of a blood sample, cefotaxime (1 gm BID) was administered intravenously for four days; if defervescence did not occur by day 5, the dosage was increased to 2 gm BID until defervescence, when it was reduced to 1 gm BID until discharge." | ( Choi, HR; Choi, HS; Kim, SY; Kim, TW; Lee, CH; Lee, MA; Park, CH; Park, SC; Seok, SE; Won, JS, 1985) |
| "Ten chronic enteric typhoid carriers treated with oral ampicillin have been followed for 4 to 9 years and no relapses have occurred." | ( Hook, EW; Johnson, WD; Kaye, D; Lindsey, E, 1973) |
| "Fifty out of 100 patients with typhoid fever, matched for age, stage of illness, and degree of fever, were treated with chloramphenicol and the other 50 were treated with chloramphenicol combined with ampicillin." | ( De Ritis, F; Giammanco, G; Manzillo, G, 1972) |
| "Four chronic typhoid carriers from the Aberdeen typhoid outbreak of 1964 were treated with trimethoprim-sulphamethoxazole." | ( Brodie, J; Livingstone, D; Macqueen, IA, 1970) |
| "Six patients with proved typhoid fever were treated with a combination of trimethoprim and sulphamethoxazole; four others were treated with chloramphenicol." | ( Akinkugbe, OO; Lewis, EA; Montefiore, D; Okubadejo, OA, 1968) |
| "Twelve patients with acute typhoid fever were successfully treated with a fixed dose combination of pivmecillinam and pivampicillin." | ( Bussayanond, A; Christensen, O; Tanphaichitra, D, 1982) |
| "Over a period of 3 years, 49 typhoid perforations of the small intestine were treated at Yaoundé Central Hospital." | ( Ibile, A; Malonga, E; Masso-Misse, P; Yao, JG, 1994) |
| "Patients with clinical typhoid fever plus a blood, bone marrow, or bile positive for Salmonella typhi or Salmonella paratyphi were included in an open clinical trial to compare the efficacy of aztreonam (6 g/day [2 g intravenously every 8 h]) given for 10 days with that of chloramphenicol (50 mg/kg of body weight per day [intravenously or orally]) administered for 14 days." | ( Carrillo, C; DuPont, HL; Echevarría, J; Gotuzzo, E; Grados, P; Maguiña, C; Sánchez, J, 1994) |
| "Two developed recurrence of paratyphoid fever, 17 days and 4 months after therapy." | ( Jesudason, MV; John, J; Kaur, A; Keystone, JS; Kozarsky, PE; Kudva, GC; Lalitha, MK; Mathai, D; Pulimood, BM; Thomas, M, 1993) |
| "Treatment of typhoid fever with furazolidone produces a high cure rate." | ( Kumar, AS; Legori, M; Mathew, R; Sathy, N, 1995) |
| "Of the 217 children with MDR typhoid who received therapy with third-generation cephalosporins, the outcome was significantly better with intravenous ceftriaxone compared with cefotaxime." | ( Bhutta, ZA, 1996) |
| "Forty cases of typhoid ileal perforation were treated surgically in three years." | ( Ahmad, G; Dab, RH; Javaid, K; Rathore, AH, 1996) |
| "17 chloramphenicol resistant typhoid cases in whom chloramphenicol was initially started failed to respond to this drug even after 4-5 days therapy, indicating that in vivo response matched with the in vitro sensitivity." | ( Agarwal, SK; Maheshwari, VD, 1996) |
| "The results of treatment of 60 cases of typhoid perforation were reviewed over a period of 4." | ( Pal, DK, 1998) |
| "To treat 212 cases of typhoid fever with Seven kinds of fluoroquinolones (FQNS) and to evaluate their clinical efficacy, bacterial susceptibility and adverse drug reaction (ADR)." | ( Feng, S; Jiang, S; Wang, X, 1997) |
| "Treatment of typhoid fever in this study showed 86% efficacy in producing clinical responses suggesting that this drug can be effectively and safely used in the treatment of typhoid fever in children." | ( Alam, SE; Dhanjee, A; Sheikh, MA; Yaqub, M, 1999) |
| "All 11 patients diagnosed as having typhoid fever had an excellent response to treatment with ciprofloxacin and dexamethasone with no mortality and with normalization of the liver test results in 2 weeks." | ( Chakraborty, A; Jalihal, A; Kamath, PS, 2000) |
| "58 patients (54 Japanese) with typhoid fever, 42 patients (41 Japanese) with paratyphoid fever, and 1 Japanese patient with both typhoid fever and paratyphoid fever, who were admitted in hospitals in Tokyo, Kawasaki, Yokohama, Kyoto, and Osaka from 1995 to 1998 and treated with fluoroquinolones." | ( Goto, T; Kim, YK; Kimura, K; Masuda, G; Obana, M; Ohnishi, K; Sagara, H; Sakamoto, M; Sakaue, Y; Tsunoda, T; Yoshida, H, 2000) |
| "Similar cases of typhoid fever responding poorly to quinolone treatment have been observed in the Indian subcontinent, south-east Asia and central Asia since the early 1990s, and potential spread by travelers into Japan is of serious concern." | ( Adachi, T; Ajisawa, A; Imamura, A; Masuda, G; Negishi, M; Takano, S; Takayama, N; Takinaga, K, 2001) |
| "In acute typhoid fever, the ability of peripheral blood leukocytes to release proinflammatory cytokines in response to an inflammatory stimulus is depressed, and this may contribute to delayed recovery following antibiotic treatment." | ( Chinh, NT; Diep, TS; Dougan, G; Dunstan, S; Farrar, JJ; Hien, TT; House, D; Ly, NT; Parry, CP; Wain, J; White, NJ, 2002) |
| "Although the efficacy of ceftriaxone in typhoid fever is well documented, the precise duration of ceftriaxone therapy in children with typhoid fever is not established and varies from 3 to 14 days in the literature." | ( Aktas, G; Kosecik, M; Tatli, MM; Yilmaz, A, 2003) |
| "As indicated by a study of 41 cases of typhoid fever treated in three years, blood culture alone is often sufficient for the diagnosis of the disease if a large (30 cc." | ( BOWER, AG, 1958) |
| "Six patients with typhoid fever were treated with chloramphenicol." | ( BOWER, AG; CHUDNOFF, JS; ROSOVE, L, 1950) |
| "None of the treated typhoid fever cases experienced a clinical relapse." | ( Chen, K; Nelwan, RH; Paramita, D, 2006) |
| "We present three cases of typhoid fever imported to Poland from India in the beginning of the year 2006 treated in our Zoonosis and Tropical Medicine Department." | ( Borkowski, PK; Olszyńiska-Krowicka, M, 2007) |
| "Patients with typhoid fever due to Salmonella enterica serotype Typhi strains for which fluoroquinolones MICs are elevated yet that are classified as susceptible by the current interpretive criteria of the Clinical and Laboratory Standards Institute may not respond adequately to fluoroquinolone therapy." | ( Angulo, FJ; Crump, JA; Gay, K; Hanna, SS; Hoekstra, RM; Hurd, S; Joyce, KW; Kretsinger, K; Luedeman, LJ; Megginson, M; Mintz, ED; Segler, SD; Shiferaw, B; Vugia, DJ, 2008) |
| "The clinical presentation of typhoid is discussed, and the literature relevant to diagnosis, treatment and prevention is reviewed." | ( Elias, AF; Huntington, MK; Peterson, SN, 2008) |
| "The burden of typhoid fever remains high in impoverished settings, and increasing antibiotic resistance is making treatment costly." | ( Agtini, M; Anh, DD; Bhutta, Z; Clemens, J; Cook, J; Jeuland, M; Poulos, C; Sur, D; Whittington, D, 2008) |
| "In this report we describe a case of typhoid fever in a Czech patient with history of travel to India and discuss antibiotic treatment failure which led to the relapse of fever." | ( Chmelarová, E; Lukácová, L; Orságová, I; Zjevíková, A, 2009) |
| "Ciprofloxacin resistant typhoid fever responds to treatment with ceftriaxone." | ( Harish, BN; Menezes, GA; Parija, SC; Sarangapani, K, 2008) |
| "The patient was treated for presumptive typhoid fever with ciprofloxacin." | ( Lahri, H; Petit, PL; van Genderen, PJ; van Wolfswinkel, ME; Wismans, PJ, 2009) |
| "We describe here a case of Salmonella typhi infection of a sacroiliac joint that was cured with ciprofloxacin therapy for six weeks." | ( Ayaz, C; Celen, MK; Geyik, MF; Hosoglu, S; Ulug, M, 2009) |
| "typhimurium C5 infected mouse model of typhoid fever to demonstrate that administration of exogenous IL-24 had a protective effect against the bacteria." | ( Chen, H; Luo, F; Ma, Y; Wang, Q; Yan, J; Zhang, XL, 2009) |
| "Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)." | ( Bukirwa, H; Effa, EE, 2011) |
| "Antibiotic treatment was initiated if typhoid diagnosis occurred (temperature ≥38°C sustained ≥12 hours or bacteremia) or at day 14 in those remaining untreated." | ( Angus, B; Darton, TC; Dougan, G; Farrar, JJ; Haworth, K; Holt, KE; John, T; Jones, C; Kerridge, SA; Kingsley, RA; Levine, MM; Lockhart, S; Peters, A; Pollard, AJ; Sztein, MB; Thompson, BA; Waddington, CS; Yu, LM; Zhou, L, 2014) |
| "During a typhoid clinical treatment trial in Nepal, we observed several treatment failures and isolated highly fluoroquinolone-resistant Salmonella Typhi (S." | ( Arjyal, A; Baker, S; Basnyat, B; Dolecek, C; Dongol, S; Dougan, G; Gajurel, D; Ha Thanh, T; Ho Thi, N; Holt, KE; Karkey, A; Parry, CM; Pham Thanh, D; Pickard, D; Pradhan, A; Rabaa, MA; Shrestha, SK; Thompson, CN; Thwaites, GE; Tran Vu Thieu, N; Voong Vinh, P; Wolbers, M; Wong, V, 2016) |
| "We discuss diagnostic methods and treatment of enteric fever with special emphasis on typhoid fever." | ( Calzadilla Riveras, J; Farías Molina, S; Hermoso, A; Sanhueza Palma, NC, 2016) |
| "We report a case of typhoid due to Salmonella Typhi which was non-responsive to treatment with a cephalosporin, was found to be multidrug resistant and resistant to ciprofloxacin and third generation cephalosporin as well." | ( Ahmed, M; Andleeb, S; Ansari, JK; Lodhi, M; Munir, T, 2016) |
| "Often patients are empirically treated as presumed enteric fever." | ( Arjyal, A; Baker, S; Basnyat, B; Bhuju, A; Dongol, S; Karkey, A; Karki, M; Kc, RK; Kestelyn, E; Mahat, SP; Phuong, DNT; Pokharel, S; Poudyal, B; Shrestha, R; Thapa, R; Thwaites, G; Wolbers, M, 2017) |
| "Ceftriaxone is the drug of choice for typhoid fever and the emergence of resistant Salmonella Typhi raises major concerns for treatment." | ( Djeghout, B; Endtz, HP; Islam, M; Kay, GL; Langridge, GC; Saha, S; Saha, SK; Sajib, MSI; Tanmoy, AM; Wain, J, 2018) |
| "During the first episode of typhoid fever, 2 of the 3 cases were treated with ceftriaxone (CRO) for 7 days, and 1 was treated for 14 days." | ( Das, S; Dutta, S; Ray, U; Samajpati, S, 2018) |
| "The cost of treating enteric fever is considerable and likely to increase with emerging antimicrobial resistance." | ( Anandan, S; Chauhan, AS; Dhas Sankhro, C; Ebenezer, SE; Gupta, M; Jinka, DR; John, J; Kang, G; Kapil, A; Karthikeyan, AS; Koshy, RM; Kumar, D; Mohan, VR; Nagaraj, S; Njarekkattuvalappil, SK; Perumal, SPB; Premkumar, PS; Prinja, S; Raju, R; Ramanujam, K; Rana, SK; Ray, P; Saigal, K; Sharma, A; Shastri, J; Singh, A; Thankaraj, S; Thomas, M; Thomas, MS, 2021) |
| "Cefixime can also be used for treatment of enteric fever but may not perform as well as fluoroquinolones." | ( Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N, 2022) |
| "Cefixime can also be used for treatment of enteric fever but may not perform as well as fluoroquinolones." | ( Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N, 2022) |
| "Cefixime can also be used for treatment of enteric fever but may not perform as well as fluoroquinolones." | ( Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N, 2022) |
| "The epidemiology and treatment of typhoid fever are complicated by the emergence and spread of Salmonella enterica subsp." | ( Clark, ST; Corbeil, AJ; Cronin, K; Patel, SN, 2023) |
| "Detarium microcarpum is used to treat typhoid fever, a major public health problem, by indigenous population in Africa." | ( Boyom, FF; Boyomo, O; Dimo, T; Fifen, R; Fokou, PVT; Fouatio, WF; Kamkumo, RG; Mbock, MA; Ndjakou, BL; Ngang, JJE; Nkengfack, AE; Noussi, CD; Sewald, N; Shukla, R; Singh, TR; Tsofack, FN, 2023) |